Imojev Powder for Suspension for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

imojev powder for suspension for injection (sc)

n/a; importer: zuellig pharma corporation; distributor: zuellig pharma corporation - japanese encephalitis virus (live, attenuated) - powder for suspension for injection (sc) - formulation: after reconstitution, one dose (0.5 ml) contains 4.0-5.8 log plaque forming units (pfu) live, attenuated, recombinant japanese encephalitis virus.

Imojev Powder for Suspension for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

imojev powder for suspension for injection (sc)

n/a; importer: zuellig pharma corporation; distributor: zuellig pharma corporation - japanese encephalitis vaccine (live, attenuated) - powder for suspension for injection (sc) - formulation: after reconstitution, one dose (0.5 ml) contains 4.0-5.8 log plaque forming units (pfu) live, attenuated, recombinant japanese encephalitis virus.

TAIPAN ANTIVENOM (equine) 12000U injection    vial Australia - English - Department of Health (Therapeutic Goods Administration)

taipan antivenom (equine) 12000u injection vial

seqirus pty ltd - taipan antivenom, quantity: 12000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a taipan.

ZULBACTAM 500mg / 250mg VIAL POWDER FOR INJECTION Philippines - English - FDA (Food And Drug Administration)

zulbactam 500mg / 250mg vial powder for injection

pan-ject pharmaceuticals corporation; distributor: marzan pharma corporation - ampicillin (as sodium) , sulbactam (as sodium) - powder for injection - 500mg / 250mg vial

OXZAN 500mg POWDER FOR INJECTION Philippines - English - FDA (Food And Drug Administration)

oxzan 500mg powder for injection

pan-ject pharmaceuticals corporation; distributor: marzan pharma corporation - oxacillin (as sodium) - powder for injection - 500mg

DIPROSPAN INJECTION Israel - English - Ministry of Health

diprospan injection

organon pharma israel ltd., israel - betamethasone as dipropionate; betamethasone sodium phosphate - suspension for injection - betamethasone sodium phosphate 2 mg/ml; betamethasone as dipropionate 5 mg/ml - betamethasone - betamethasone - produces anti-inflammatory, anti rheumatic and anti-allergic action and is indicated for systemic and local therapy of acute and chronic corticosteroid-responsive disorders.

DIPROSPAN INJECTION Singapore - English - HSA (Health Sciences Authority)

diprospan injection

msd pharma (singapore) pte. ltd. - betamethasone dipropionate eqv betamethasone alcohol; betamethasone disodium phosphate eqv betamethasone alcohol - injection - 5 mg/ml - betamethasone dipropionate eqv betamethasone alcohol 5 mg/ml; betamethasone disodium phosphate eqv betamethasone alcohol 2 mg/ml

Clindazan 150 mg/mL (600 mg/4mL) Solution for Injection (IM/IV) Philippines - English - FDA (Food And Drug Administration)

clindazan 150 mg/ml (600 mg/4ml) solution for injection (im/iv)

for: vitalis sociedad anonima c.i.; importer: pan-ject pharmaceuticals corp.; distributor: marzan pharma corporation - clindamycin (as phosphate) - solution for injection (im/iv) - 150 mg/ml (600 mg/4ml)

MEFOXITIN 1g Powder for Injection (IM / IV) Philippines - English - FDA (Food And Drug Administration)

mefoxitin 1g powder for injection (im / iv)

vitalis s.a.c.i. - colombia; importer: pan-ject pharmaceutical corporation; distributor: marzan pharma corporation - cefoxitin sodium - powder for injection (im / iv) - 1g

OCTREOTIDE SUN octreotide (as acetate) 50 microgram/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

octreotide sun octreotide (as acetate) 50 microgram/1 ml solution for injection ampoule

sun pharma anz pty ltd - octreotide, quantity: 50 microgram - injection, solution - excipient ingredients: water for injections; sodium chloride; glacial acetic acid; sodium acetate trihydrate - for symptomatic control and reduction of growth hormone and igf-l plasma levels in patients with acromegaly, including those who are inadequately controlled by surgery, radiotherapy, or dopamine agonist treatment. octreotide treatment is also indicated in acromegalic patients unfit or unwilling to undergo surgery, or in the interim period until radiotherapy becomes fully effective.,for the relief of symptoms associated with the following functional tumours of the gastro-entero-pancreatic endocrine system: - carcinoid tumours with features of the carcinoid syndrome - vasoactive intestinal peptide secreting tumours [vipomas] octreotide is not curative in these patients.,for reduction of the incidence of complications following pancreatic surgery.